LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Part of paid clinical trials in Alexander City, Alabama.
- Sponsor
- Tenax Therapeutics, Inc.
- Study ID
- NCT07288398
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Pulmonary Hypertension Associated With HFpEF
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- TNX-103 — DRUGOral levosimendan
- Placebo — DRUGMatching placebo (oral)
Study Details
The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance.
Key Dates
- Start date
- Mar 3, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 540 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboMatching placebo (oral)
- Active Comparator: TNX-103Oral levosimendan
Primary Outcome Measure
6-Minute Walk Distance (6MWD) [ Time Frame: 26 weeks ]
Central Contacts
- Akshata Ashokkumar(919) 855-2118
- Katelyn Jansson(919) 855-2119
Locations (18)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Tenax Investigational Site | Alexander City | Alabama | 35010 | - |
| Tenax Investigational Site | Tamarac | Florida | 33321 | - |
| Tenax Investigational Site | Mount Prospect | Illinois | 60056 | - |
| Tenax Investigational Site | Peoria | Illinois | 61636 | - |
| Tenax Investigational Site | New Orleans | Louisiana | 70115-6969 | - |
| Tenax Investigational Site | West Monroe | Louisiana | 71291 | - |
| Tenax Investigational Site | Ypsilanti | Michigan | 48197 | - |
| Tenax Investigational Site | Reno | Nevada | 89502 | - |
| Tenax Investigational Site | New York | New York | 10032 | - |
| Tenax Investigational Site | Winston-Salem | North Carolina | 27101 | - |
| Tenax Investigational Site | Allentown | Pennsylvania | 18105 | - |
| Tenax Investigational Site | Wynnewood | Pennsylvania | 19096-3450 | - |
| Tenax Investigational Site | Nashville | Tennessee | 37205 | - |
| Tenax Investigational Site | Austin | Texas | 78705 | - |
| Tenax Investigational Site | Dallas | Texas | 75390 | - |
| Tenax Investigational Site | Houston | Texas | 77002 | - |
| Tenax Investigational Site | Norfolk | Virginia | 23507-1904 | - |
| Tenax Investigational Site | Marshfield | Wisconsin | 54449 | - |
Find similar trials in Alexander City, AL
Related Studies
- Long-Term Open-Label Extension Study of Oral LevosimendanPHASE3 · Enrolling By Invitation · Tenax Therapeutics, Inc. · Chicago, Illinois